S Shahidi, K Rostamizadeh, M Fathi,
K Nedaei… - … Medicine and Therapies, 2022 - Springer
Background Colorectal cancer (CRC) is the second leading cause of cancer death. Although
Regorafenib showed survival benefits in patients with CRC, reports imply the recurrence of …